“PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS”. 2023. International Research Journal of Pharmacy 14 (2): 40-48. https://doi.org/10.56802/enp5vh61.